Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
  • Technology
    • About SeptiCyte™
    • FDA Clearance – Clinical Validation
  • Partners
    • Partnership with Biocartis
    • Collaborations
  • Newsroom
  • Contact Us
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
  • Technology
    • About SeptiCyte™
    • FDA Clearance – Clinical Validation
  • Partners
    • Partnership with Biocartis
    • Collaborations
  • Newsroom
  • Contact Us

Media Contacts

If you are a member of the media, please contact:

Maggie Beller

Russo Partners

(646) 942-5631

maggie.beller@russopartnersllc.com

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom

Contact Us

Privacy policy

 

Tweets by @Immunexpress

© 2018 Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 430, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com